Connor, Clark & Lunn Investment Management (CC&L)’s Aldeyra Therapeutics ALDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-169,306
| Closed | -$1.42M | – | 1345 |
|
|
2023
Q2 | $1.42M | Sell |
169,306
-13,764
| -8% | -$115K | 0.01% | 692 |
|
|
2023
Q1 | $1.82M | Sell |
183,070
-1,824
| -1% | -$18.1K | 0.01% | 576 |
|
|
2022
Q4 | $1.29M | Sell |
184,894
-41,303
| -18% | -$287K | 0.01% | 649 |
|
|
2022
Q3 | $1.21M | Buy |
226,197
+158,283
| +233% | +$845K | 0.01% | 608 |
|
|
2022
Q2 | $271K | Buy |
+67,914
| New | +$271K | ﹤0.01% | 882 |
|
|
2020
Q3 | – | Sell |
-16,346
| Closed | -$68K | – | 917 |
|
|
2020
Q2 | $68K | Sell |
16,346
-83,376
| -84% | -$347K | ﹤0.01% | 973 |
|
|
2020
Q1 | $246K | Buy |
99,722
+10,225
| +11% | +$25.2K | ﹤0.01% | 833 |
|
|
2019
Q4 | $520K | Buy |
89,497
+12,325
| +16% | +$71.6K | ﹤0.01% | 656 |
|
|
2019
Q3 | $407K | Sell |
77,172
-18,687
| -19% | -$98.6K | ﹤0.01% | 729 |
|
|
2019
Q2 | $575K | Buy |
95,859
+13,775
| +17% | +$82.6K | ﹤0.01% | 691 |
|
|
2019
Q1 | $741K | Buy |
82,084
+34,904
| +74% | +$315K | ﹤0.01% | 592 |
|
|
2018
Q4 | $392K | Buy |
+47,180
| New | +$392K | ﹤0.01% | 751 |
|